Nathalie Bonnefoy
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Cancer-associated mesothelial cells drive immune escape and therapy resistance in ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: June 25, 2026
TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer.
Journal: eLife
Published: October 21, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.
Journal: Journal for immunotherapy of cancer
Published: March 01, 2025
FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 16, 2024
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment.
Journal: British journal of cancer
Published: February 01, 2024
Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness.
Journal: Frontiers in immunology
Published: February 20, 2023
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.
Journal: Seminars in immunopathology
Published: September 22, 2022
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry.
Journal: Autoimmunity reviews
Published: September 11, 2022
A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry.
Journal: Frontiers in immunology
Published: August 04, 2022
Last Updated: 09/26/2026